Trial intelligence / Profile preview

Twice Yearly Treatment for the Control of Lymphatic Filariasis

PACTR201702002012425Not yet recruiting

Sponsor
European & Developing Countries Clinical Trials Partnership
Start
Mar 2017
Countries
1
01

Overview

Open-label trial in filariasis (2 arms), sponsored by European & Developing Countries Clinical Trials Partnership. Primary endpoint: Change from baseline prevalence of lymphatic filariasis at 24 months. Planned start Mar 2017; status: not yet recruiting.

02

Conditions

filariasis

Beyond the preview

Go deeper on PACTR201702002012425.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201702002012425.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call